Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 5 studies | 19% ± 3% | |
amacrine cell | 4 studies | 31% ± 9% | |
retina horizontal cell | 4 studies | 26% ± 5% | |
endothelial cell | 4 studies | 22% ± 6% | |
retinal bipolar neuron | 3 studies | 35% ± 14% | |
OFF-bipolar cell | 3 studies | 27% ± 9% | |
ON-bipolar cell | 3 studies | 26% ± 9% | |
epithelial cell | 3 studies | 23% ± 5% | |
rod bipolar cell | 3 studies | 27% ± 6% | |
keratinocyte | 3 studies | 25% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 5 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 94% | 5945.20 | 243 / 258 | 98% | 77.07 | 225 / 230 |
ovary | 94% | 7969.84 | 169 / 180 | 89% | 17.08 | 382 / 430 |
breast | 90% | 7838.34 | 411 / 459 | 93% | 26.49 | 1041 / 1118 |
esophagus | 81% | 4423.74 | 1176 / 1445 | 100% | 49.67 | 183 / 183 |
uterus | 91% | 6576.65 | 155 / 170 | 90% | 31.30 | 413 / 459 |
kidney | 83% | 3748.67 | 74 / 89 | 97% | 40.30 | 877 / 901 |
bladder | 90% | 5184.19 | 19 / 21 | 88% | 22.86 | 441 / 504 |
brain | 77% | 3640.33 | 2033 / 2642 | 99% | 41.77 | 701 / 705 |
lung | 85% | 5472.03 | 489 / 578 | 91% | 29.27 | 1055 / 1155 |
skin | 74% | 25036.66 | 1344 / 1809 | 99% | 33.57 | 467 / 472 |
intestine | 74% | 3980.19 | 716 / 966 | 98% | 31.85 | 516 / 527 |
prostate | 87% | 4878.96 | 214 / 245 | 84% | 15.37 | 420 / 502 |
thymus | 72% | 3778.74 | 468 / 653 | 96% | 60.82 | 581 / 605 |
stomach | 64% | 2410.01 | 230 / 359 | 98% | 30.69 | 280 / 286 |
liver | 56% | 2036.69 | 127 / 226 | 91% | 27.64 | 371 / 406 |
pancreas | 33% | 887.82 | 109 / 328 | 98% | 39.38 | 174 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 39.80 | 80 / 80 |
tonsil | 0% | 0 | 0 / 0 | 100% | 51.15 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.84 | 1 / 1 |
muscle | 96% | 6691.01 | 771 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 7310.53 | 1195 / 1335 | 0% | 0 | 0 / 0 |
adipose | 86% | 7247.16 | 1034 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 10.15 | 21 / 29 |
heart | 61% | 3153.43 | 521 / 861 | 0% | 0 | 0 / 0 |
spleen | 29% | 670.83 | 71 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 5% | 98.73 | 43 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0061469 | Biological process | regulation of type B pancreatic cell proliferation |
GO_0005978 | Biological process | glycogen biosynthetic process |
GO_0044321 | Biological process | response to leptin |
GO_0061889 | Biological process | negative regulation of astrocyte activation |
GO_0010498 | Biological process | proteasomal protein catabolic process |
GO_0070859 | Biological process | positive regulation of bile acid biosynthetic process |
GO_0034144 | Biological process | negative regulation of toll-like receptor 4 signaling pathway |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0019216 | Biological process | regulation of lipid metabolic process |
GO_1903979 | Biological process | negative regulation of microglial cell activation |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0031648 | Biological process | protein destabilization |
GO_0001678 | Biological process | intracellular glucose homeostasis |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0150079 | Biological process | negative regulation of neuroinflammatory response |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0061178 | Biological process | regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0030154 | Biological process | cell differentiation |
GO_0042749 | Biological process | regulation of circadian sleep/wake cycle |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0043401 | Biological process | steroid hormone receptor signaling pathway |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0045598 | Biological process | regulation of fat cell differentiation |
GO_0060086 | Biological process | circadian temperature homeostasis |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0043197 | Cellular component | dendritic spine |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0016604 | Cellular component | nuclear body |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003707 | Molecular function | nuclear steroid receptor activity |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0020037 | Molecular function | heme binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0070888 | Molecular function | E-box binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR1D1 |
Protein name | Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1) Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) |
Synonyms | THRAL HREV hCG_93862 EAR1 |
Description | FUNCTION: Transcriptional repressor which coordinates circadian rhythm and metabolic pathways in a heme-dependent manner. Integral component of the complex transcription machinery that governs circadian rhythmicity and forms a critical negative limb of the circadian clock by directly repressing the expression of core clock components BMAL1, CLOCK and CRY1. Also regulates genes involved in metabolic functions, including lipid and bile acid metabolism, adipogenesis, gluconeogenesis and the macrophage inflammatory response. Acts as a receptor for heme which stimulates its interaction with the NCOR1/HDAC3 corepressor complex, enhancing transcriptional repression. Recognizes two classes of DNA response elements within the promoter of its target genes and can bind to DNA as either monomers or homodimers, depending on the nature of the response element. Binds as a monomer to a response element composed of the consensus half-site motif 5'-[A/G]GGTCA-3' preceded by an A/T-rich 5' sequence (RevRE), or as a homodimer to a direct repeat of the core motif spaced by two nucleotides (RevDR-2). Acts as a potent competitive repressor of ROR alpha (RORA) function and regulates the levels of its ligand heme by repressing the expression of PPARGC1A, a potent inducer of heme synthesis. Regulates lipid metabolism by repressing the expression of APOC3 and by influencing the activity of sterol response element binding proteins (SREBPs); represses INSIG2 which interferes with the proteolytic activation of SREBPs which in turn govern the rhythmic expression of enzymes with key functions in sterol and fatty acid synthesis. Regulates gluconeogenesis via repression of G6PC1 and PEPCK and adipocyte differentiation via repression of PPARG. Regulates glucagon release in pancreatic alpha-cells via the AMPK-NAMPT-SIRT1 pathway and the proliferation, glucose-induced insulin secretion and expression of key lipogenic genes in pancreatic-beta cells. Positively regulates bile acid synthesis by increasing hepatic expression of CYP7A1 via repression of NR0B2 and NFIL3 which are negative regulators of CYP7A1. Modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy; controls mitochondrial biogenesis and respiration by interfering with the STK11-PRKAA1/2-SIRT1-PPARGC1A signaling pathway. Represses the expression of SERPINE1/PAI1, an important modulator of cardiovascular disease and the expression of inflammatory cytokines and chemokines in macrophages. Represses gene expression at a distance in macrophages by inhibiting the transcription of enhancer-derived RNAs (eRNAs). Plays a role in the circadian regulation of body temperature and negatively regulates thermogenic transcriptional programs in brown adipose tissue (BAT); imposes a circadian oscillation in BAT activity, increasing body temperature when awake and depressing thermogenesis during sleep. In concert with NR2E3, regulates transcriptional networks critical for photoreceptor development and function. In addition to its activity as a repressor, can also act as a transcriptional activator. In the ovarian granulosa cells acts as a transcriptional activator of STAR which plays a role in steroid biosynthesis. In collaboration with SP1, activates GJA1 transcription in a heme-independent manner. Represses the transcription of CYP2B10, CYP4A10 and CYP4A14 (By similarity). Represses the transcription of CES2 (By similarity). Represses and regulates the circadian expression of TSHB in a NCOR1-dependent manner (By similarity). Negatively regulates the protein stability of NR3C1 and influences the time-dependent subcellular distribution of NR3C1, thereby affecting its transcriptional regulatory activity (By similarity). Plays a critical role in the circadian control of neutrophilic inflammation in the lung; under resting, non-stress conditions, acts as a rhythmic repressor to limit inflammatory activity whereas in the presence of inflammatory triggers undergoes ubiquitin-mediated degradation thereby relieving inhibition of the inflammatory response (By similarity). Plays a key role in the circadian regulation of microglial activation and neuroinflammation; suppresses microglial activation through the NF-kappaB pathway in the central nervous system (By similarity). Plays a role in the regulation of the diurnal rhythms of lipid and protein metabolism in the skeletal muscle via transcriptional repression of genes controlling lipid and amino acid metabolism in the muscle (By similarity). . |
Accessions | ENST00000246672.4 P20393 F1D8S3 |